Wellington Management Company »

Forte Biosciences shares owned by Wellington Management Company

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $764k 30k 25.90

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Johnson & Johnson (JNJ)
Astrazeneca Ord (AZN)
Sempra Energy (SRE)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wellington Management Company

Top funds holding Forte Biosciences

Federated Investors
Fred Alger Management
OrbiMed Advisors
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
Adage Capital Partners GP
Vanguard Capital Management
Morgan Stanley
Cable Car Capital
FMR
Millennium Management
Woodline Partners
Citadel Advisors
AWM Investment Company

View all funds holding Forte Biosciences